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Abstract: We herein hypothesize that bioceramics with an appropriate architecture made of
Si-αtricalcium phosphate (Si-αTCP) meet the biocompatibility and biological safety requirements
for bone grafting applications. Polyurethane sponges were used as templates, soaked with ceramic
slurry at different ratios and sintered at 1400 ◦C for 3 h at heating and cooling rates of 5 ◦C/min.
Four critical size defects of 6 mm Ø were created in 15 NZ tibias. Three working times were
established as 15, 30 and 60 days. A highly porous Si-αTCP scaffold with micro and macropores
and pore interconnectivity was produced by the polymer replication method. Considerably more
bone formation took place in the pores and the periphery of the implant for the Si-αTCP scaffolds
than for the control group. The ceramic scaffold (68.32% ± 1.21) generated higher bone-to-implant
contact (BIC) percentage values (higher quality, closer contact) than the control group, according
to the histomorphometric analysis, and defect closure was significant compared with the control
group. The highest percentages of BIC and bone formation were found after 60 days of implantation.
These results suggest that the Si-αTCP scaffold is advantageous for initial bone regeneration.
Keywords: polymer replication method; porous bioceramics; tricalcium phosphate; in vivo response;
tissue reaction; biocompatibility
1. Introduction
The features of the new generation of tissue engineering scaffolds for bone regeneration purposes
include being degradable, highly bioactive and mechanically strong [1,2]. Among the many essential
factors for tissue engineering scaffolds, macroporous morphology and bioactive composition are
assumed to be critical for impacting cell response [3–6].
There are three polymorphs of tricalcium phosphate (TCP): the low-temperature βTCP and the
high-temperature forms α and α′TCP. This last form lacks practical interest because it only exists at
temperatures ≥1430 ◦C and reverts almost instantaneously to αTCP on cooling below the transition
temperature. In contrast, βTCP is stable at room temperature and transforms reconstructively [7,8] at
≥1125 ◦C to αTCP, which can be retained during cooling to room temperature [9].
α- and βTCP are currently used in several clinical applications in dentistry, maxillofacial surgery
and orthopaedics: βTCP is a component in several commercial mono or biphasic bioceramics and
composites and αTCP is the major constituent of the powder component of various hydraulic bone
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cements [9–12]. In spite of having the same chemical composition, α- and βTCP differ considerably
in their structure, density and solubility, which in turn determine their biological properties and
clinical applications.
From a biological point of view, αTCP is non-toxic, osteoconductive and bioactive, both in vitro
and in vivo. The main reason for the growing interest in αTCP as a bone implant material is its
biodegradability. It is more bioreabsorbable than hydroxyapataie (HA),βTCP and biphasic (HA/βTCP)
bioceramics currently used in clinical practice. This makes αTCP an ideal implant material which is
able to be replaced by new bone faster than the other calcium–phosphate-based materials currently
available on the market.
One of our recent works involved synthesizing a new form of αTCP doped with dicalcium silicate
(C2S) bioceramic powders in the silicocarnotite-tricalcium phosphate subsystem [13] and additional
prepared dense αTCP doped ceramic discs by solid-state processing [14]. One of our former studies
has reported the exceptional carbo-hydroxyapatite mineralization ability of αTCP doped ceramic
discs in simulated body fluids [15,16]. The released Ca, Si and P, which contained the ionic products
from α-TCP doped ceramic, greatly promoted osteogenic differentiation of human mesenchymal stem
cells [17,18]. Mate-Sanchez et al. found that Si-TCP grafts displayed greater dimensional stability and
better bone to implant contact (BIC) at a % reabsorption rate of ~71.5% of α-TCP and ~42.2% of Si-TCP
at day 60 of implantation [19–21]. What these findings indicate is that the chemical composition of
Si-αTCP bioceramics is key to enhancing the in vivo behavior of TCP implants.
However, to date, studies on Si-αTCP bioceramics have worked with ceramic discs; hence, none
have reported on the fabrication and properties of three-dimensional (3-D) scaffolds. Developing
porous Si-αTCP scaffolds to be used as carriers for bone tissue development or as specific release
vehicles is therefore of much interest.
Three-dimensional scaffolds for bone tissue engineering are subject to many interrelated biological
and structural requirements which must be taken into consideration when selecting the suitable
biomaterial for fabrication. An ideal bone tissue scaffold should possess an interconnected porous
structure; i.e., it should be highly permeable, with a porosity of >90% and pore diameters in the range
10–500 µm for cell seeding, tissue ingrowth and vascularization, as well as for nutrient delivery and
waste removal [22–27]. A particular design criterion of tissue engineering scaffolds is the mimicry
and implementation of the bimodal porosity of cancellous bone tissue, which is an important factor
for effective scaffold vascularization and for bone ingrowth [28]. Microporosity (≈2–10 µm, <50 µm)
is essential for immediate protein and cell adhesion, cell migration and osteointegration [23,24,27].
Higher pore sizes (>300 µm) are required for enhanced new bone formation, greater bone ingrowth
and the formation of capillaries [22,23,25,29,30].
In this study, we applied a polymer replication method [22,31–33] to prepare Si-α-TCP scaffolds
with a highly-controlled macro and micro structure and pore interconnectivity and we investigated
how their pore morphology affected their osteoconductivity and resorption process in vivo for the
first time.
2. Materials and Methods
2.1. Preparation and Characterization of the Si-TCP Scaffolds
Dicalcium silicate and tricalcium ceramic powder were synthetized in our laboratory, according
to the previously-described processing [8,10].
The dicalcium silicate and tricalcium phosphate in a 3:97 weight % ratio were crushed into dust
in an attrition-mill with isopropilic alcohol as liquid medium and ZrO2-Y2O3 balls (1 mm in diameter)
for a total of 5 h. A ceramic slurry was prepared with 70% solid contents with a ceramic particle size of
2.1 µm (Mastersizer, Malvern, PA, USA) in a water media. We used 4 weight % of binder (Optapix
PAF-35—Zschimmer Schwartz, Germany) and 2 weight % of defloculant (Dolapix CE-64—Zschimmer
Schwartz, Germany). The powder/water ratio was 65:35.
Appl. Sci. 2017, 7, 706 3 of 11
Polyurethane sponges with open cells measuring 60 ppi (BULPREN S. Eurofoam GmbH.
Wiesbaden, Germany) were used as templates, soaked with ceramic slurry and sintered at 1400 ◦C for
3 h at heating and cooling rates of 5 ◦C/min. Then power was turned off and samples were allowed to
cool inside the furnace for 24 h. The final scaffolds had a diameter of 6 mm and a length of 5 mm.
Crystalline phases present in the raw ceramics and in the sintered Si-TCP scaffolds were identified
by X-ray diffraction (XRD, Bruker-AXS D8Advance, Karlsruhe, Germany) with a step size of 0.02◦ at a
scanning rate of 10◦·min−1 within the 2θ range of 10–50◦, and were observed by scanning electron
microscopy (SEM) (Hitachi S-3500N, Ibaraki, Japan) at an accelerating voltage of 20 kV. The pore
distribution, pore area, average pore diameter and porosity of the prepared scaffolds were tested by
mercury intrusion porosimetry (Quantachrome, Boynton Beach, FL, USA).). The mechanical properties
of the scaffolds were measured by the Brazilian test or by the Diametrical Compression of Discs Test
(DCDT). Circular discs of a diameter (D) of ~16.60 mm and a thickness (t) of ~5.00 mm (t/D ~ 0.30)
were placed between two stainless steel loading plates with their faces perpendicular to the loading
plates in a universal testing machine (Model AME-5kN, technical Industrial Oawaldo, Filizola Ltda,
Guarulhos, Brazil). A load was applied at the displacing rate of the machine frame of 0.5 mm/min and
was applied until the scaffold cracked. The results of 10 valid tests were used to calculate diametrical
strength by the procedure of ISO 14801 [34].
2.2. Animals and Surgical Procedure
The Animal Ethics Committee of the Miguel Hernandez University approved the study
protocol, which followed Spanish Government and European Community Guidelines for animal
care (authorized No. 2014/VSC/PEA/00056 tipo2). The study used 15 male New Zealand rabbits that
weighed 3.5–4.5 kg. The Si-TCP scaffold was implanted into two circular critical-size defects (6 mm Ø,
5 mm long) in the animals’ tibiae. The total sample size was 15 rabbits with two defects in each tibia,
a total of 60 defects, divided randomly into two groups of 30: a test group (Si-TCP scaffold) and a
control group (randomization). The surgical procedure and the animals sacrificed were previously
reported by our group [12–14].
2.3. Histological and Histomorphometric Analysis
After 15, 30 and 60 days, the implants, together with the surrounding tissues, were removed and
fixed in 10% neutral buffered formalin and decalcified. The decalcification method utilized Osteomoll
(Merck KGaA, Darmstadt, Germany) containing HCl (10%) and CH2O (4%), immersing samples for
17 days and renewing the solution every 24 h. The decalcified samples were cleaned and dehydrated
in a series of graded ethanol solutions and were embedded in paraffin. The regions that contained
implants were cut into 5-µm thick sections with a rotary microtome (Microm HM 340E. Waldorf,
Germany) and were stained using hematoxylin-eosin.
The standardized nomenclature of the American Society of Bone and Mineral Research was used
for histomorphometric evaluations using Image J software (developed by the National Institute of
Health, Bethesda, MD, USA). The entire circumference of each section (containing bone, implant
and connective tissue) was traced manually to create an individual region of interest (ROI).
Histomorphometric evaluations consisted of measurements of the area of implant material in relation
to the total area of interest. Reabsorption was calculated, setting the perimeter area of biomaterial at
a baseline and, after the period of analysis, the comparison between them resulted in a resorption
rate which was measured as a percentage. The established ROI area was around the perimeter of
the biomaterial at the beginning and end of the study period. Examinations were done under a
Nikon Elipse 80i microscope (Teknooptik AB, Huddinge, Sweden) equipped with the Easy Image 2000
system (Teknooptik AB), which used 10× to 40× lenses for descriptive evaluations and morphometric
measurements. Images were generated with a Leica Z6 APO microscope connected to a Leica DC 500
(Leica, Barcelona, Spain) digital camera, enlarged 23×. After calibrating the system and digitalizing
images, interactive measurements of the individual regions of interest (ROIs) were obtained by Leica
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QWin V3 image analysis software (Barcelona, Spain). The histomorphometric analysis produced one
BIC measurement, measured as the percentage of the circumference and length of the cylinder that
came into contact with new bone. In the same way, the cortical bone defect in the control group was
also evaluated.
The scaffold’s resorption rate was determined by an Image J image analysis program
(National Institutes of Health, Bethesda, MD, USA), measuring the perimeter of the scaffold after
implantation and comparing it with the residual scaffold after 15, 30 and 60 days.
To evaluate the continuing effect of Si-α-TCP scaffold implants from an ultrastructural
point of view, cross-sections of the non-decalcified tissues were examined in scanning electron
microscopy-energy-dispersive X-ray spectroscopy (SEM-EDS) according to the previously reported
SEM protocol [12–14].
2.4. Statistical Analysis
The statistical analysis was performed with PASW Statistics v.20.0.0 software (SPSS Inc., Chicago,
IL, USA). Sample size was pre-calculated using the statistical method provided by the software. Values
were recorded as means ± standard deviation and medians. A pre-statistical analysis of sample
distribution was performed to evaluate normality. A nonparametric Wilcoxon test for related samples
was applied to compare the means by assuming a 95% level of significance (p < 0.05).
3. Results
3.1. Implant Characterization
The polymer replication method enabled the production of highly porous Si-αTCP scaffolds
(Figure 1A). Pore diameters that fell within the 300 µm to 1.0 mm range and a pore wall thickness
of ~60 µm were revealed in the SEM observations (Figure 1B), as were micropores from 1 to 15 µm
on struts and pore walls (Figure 1C). A quantitative analysis by EDS was run at different sample
points, which determined that scaffold composition was around 0.29 wt % SiO2, 54.26 wt % CaO
and 45.49% P2O5. The fact that the apparent density was 70 g·cm−3 implied a total porosity of 80%.
Hg porosimetry (Poremaster, Quantachrome, Boynton Beach, FL, USA) demonstrated that 15% of
pores were bigger than 1 mm, 20% fell within the 1000–100 µm range and all the rest were under 100
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Figure 1. (A) Optical image of the Si-αTCP scaffolds obtained by the polymer replication method;
(B) A low-magnification SEM view of the scaffolds showing interconnectivity and high porosity;
(C) The high-magnification view of the scaffold reveals a well-distributed microporosity.
The XRD analysis (Figure 2) demonstrates how the prepared scaffolds have a high-temperature
metastable α-TCP crystal phase, in spite of the addition of C2S. The β-TCP to α-TCP transition in
TCP took place at 1125 ◦C [16]. However, the presence of a solid solution of Si in the TCP shifted the
transition temperature to lower temperatures. This solid solution explained the presence of the α–TCP
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polymorph at room temperature and also explained why the peaks of the JCPD card: 09-0348 and the





















noted  in  the  control  group, which might  be  expected  of  a  critical  defect.  The  scaffold  samples’ 
resorption pattern presented  numerous  resorption  foci  both  inside  and  on  the  scaffold  surfaces, 




Figure 2. The X-ray diffraction (XRD) pattern of the Si-αTCP scaffolds. All peaks correspond to a
high-temperature polymorph of TCP.
3.2. In Vivo Implant Characterization
Figure 3 shows the histological results of the Si-αTCP scaffolds implanted at 15, 30 and 60 days.
Not only did all the animals survive the 60-day study period, no evidence of inflammatory cells or
fibrous type immediate weaving at the place of bone neoformation was observed.
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Figure 3. Histomorpho etrical analysis of the Si-TCP scaf olds. ( ) 15; (B) 30 and (C) 60 days after
implantation. Light gray and dark gray areas are residual biomaterial without resorption. The yel ow
zones cor espo The regions of int rest (ROIs) correspond o the red rectangles.
The green color nside the ROI is the biomateri l and th red color is bone. The red c lor in the mi dle
of the ROI is new bone and the red colo in h p is thinner than the
old one.
In all the sa ples, oven bone was found in close contact with the scaffold and around it.
As expected in rabbit tibial bone, s all marrow spaces were noted in the peri-material bone and
reached maturity at 15 days as opposed to 60 days. Scaffold volume progressively decreased over the
study period. It started with minimal signs at 15 days until the scaffold reabsorbed at 60 days and
displayed increased new bone formation at the periphery and within the scaffold pores, which led to it
virtually disappearing and a nearly complete cortex closure by day 60. No spontaneous defect closure
was noted in the control group, which might be expected of a critical defect. The scaffold sa ples’
resorption pattern presented numerous resorption foci both inside and on the scaffold surfaces, which
generated an irregular pattern. There is an increased bone formation in the medullar zone, together
with the remaining scaffold particles surrounded by the new bone.
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Bone tissue remodeling was observed in the walls of the control defect at day 60 with abundant







































































Figure  5  depicts  the  SEM  image  of  the  implant’s  polished  cross‐section  at  15,  30  and  60 
implantation days. The cross‐sectional SEM assessment examination showed  that all  the  implants 
were  well  integrated  into  the  host  tissue  and  developed  an  irregular  surface  caused  by  their 
degradation. 
After  15  implantation  days,  newly  formed  bone  tissue  covered  the whole  ceramic  implant 




to‐biomaterial  interface  (Figure 5B,F). The new bone  that  filled pores  (Figure 5C,F) and  loosened 
particles (Figure 5D,E) were embedded partly in new bone tissue. In all the samples, bone integration 
was well advanced and bone penetration had been completed throughout central and deep areas. 
Figure 4. Histological analysis of the control group. In (A), samples at 15 days after placement of the
critical defects, the samples showed an intensive granulation reaction area; in (B), samples at 30 days,
where the bone defect began to be filled by the bone matrix from the border of the lesion; and, in (C),
60 days after injury, the defect was closed but the new bone formed was of poor quality, mainly in the
center of the defect.
The histomorph metric quantification results are shown in Table . Ana y s were run to
determine the scaffold’s BIC valu and gave high BIC values (68.32 ± 1.21 *). A close co tact was
noted. New bone ingrowth, conn ctive tissue, defect closure and a residual scaffold were analyzed
and recorded and high values were obtained for the implant scaffold samples.
Table 1. The histomophomet ic analysis to evaluate the BIC for the Si-TCP scaffold.
Test Group Control
% 15 Days 30 Days 60 Days p Values * p Values** 15 Days 30 Days 60 Days
BIC 54.34 ± 0.32(54.34)
60.33 ± 0.13
(60.33)
68.32 ± 1.21 **
(68.32) * 0.014 0.038 0.00 ± 0.0 0.00 ± 0.0 0.00 ± 0.0
New Bone 48.83 ± 1.32(48.83)
5 .26 ± 0.95 *
(52.26)
60.11 2.01 **
(60.11) * . 28 0. 11
26.07 ± 0.05
(26.07)
26.26 ± 0.43 *
(26.26)
27.10 ± 0.32 **
(27.10) *
Residual 32.18 ± 1.75(32.18)
29.94 ± 13 *
(29.94)
23.75 ± 0.85







79.01 ± 94 **
(79.01) * 0.015 0.014
10.87 ± 0.23
(10.87)
25.56 ± 0.43 *
(25.56)

















(16.14) 0.036 0.022 0.00 ± 0.0 0.00 ± 0.0 0.00 ± 0.0
Nonparametric Friedman test. Significant differences p < 0.05. Mean ± standard deviation (Median). * Differences
between 15 and 30 days for each item. ** Differences between 30 and 60 days for each item.
Figure 5 depicts the SEM image of the implant’s polished cross-section at 15, 30 and
60 implantation days. The cross-sectional SEM assessment examination showed that all the
implants were well integrated into the host tissue and developed an irregular surface caused by
their degradation.
After 15 implantation days, newly formed bone tissue covered the whole ceramic implant surface
(Figure 5A). The new bone layer co prised Ca-P, largely with traces of Si, given the progressive
diffusion of Si ions from the scaffolds to the newly forming bone, which formed part of the biomaterial’s
resorption process.
A f w proje tions of wly formed bon that reached scaffold particles characte ized the
bone-to-biomaterial interface (Figure 5B,F). The new bone that filled pores (Figure 5C,F) and loosened
particles (Figure 5D,E) were embedded partly in new bone tissue. In all the samples, bone integration
was well advanced and bone penetration had been completed throughout central and deep areas.















their degradation  status. For  the  statistical data, a  relatively high Ca/P  ratio was obtained  in  the 
residual scaffolds—1.366 ≤ Ca/P ≤ 1.74—and at the bone interface—2.02 ≤ Ca/P ≤ 2.34—according to 
the elemental analysis and when compared to new bone—1.81 ≤ Ca/P ≤ 1.98. The pre‐implantation 








(wt %)  O  Ca P Si Ca/P Ratio 
Implant/Scaffold 
15 days  44.73 ± 0.12 (44.73)  35.01 ± 0.25 (32.01)  20.25 ± 0.46 (20.25)  0.11 ± 1.62 (0.11)  1.74 ± 0.86 (1.74) 
30 days  45.43 ± 0.13 (45.43)  32.12 ± 0.24 (32.14)  22.36 ± 0.43 (22.36)  0.09 ± 1.83 (0.09)  1.44 ± 0.84 (1.44) 
60 days  48.47 ± 0.12 (48.47)  29.62 ± 0.26 (29.62)  21.84 ± 0.35 (21.84)  0.07 ± 1.82 (0.07)  1.36 ± 0.76 (1.36) 
Bone Interfase 
15 days  50.68 ± 0.11 (50.68)  32.95 ± 0.31 (32.95)  16.32 ± 0.53 (16.32)  0.05 ± 1.63 (0.05)  2.02 ± 0.95 (2.02) 
30 days  55.88 ± 0.10 (55.88)  30.23 ± 0.29 (30.23)  13.85 ± 0.54 (13.85)  0.04 ± 1.33 (0.04)  2.18 ± 0.84 (2.18) 
60 days  59.15 ± 0.12 (59.15)  28.62 ± 0.32 (28.62)  12.21 ± 0.75 (12.21)  0.02 ± 1.25 (0.02)  2.34 ± 0.96 (2.34) 
New bone 
15 days  59.69 ± 0.15 (59.69)  26.78 ± 0.16 (26.78)  13.5 ± 0.62 (13.50)  0.02 ± 1.63 (0.02)  1.98 ± 0.83 (1.98) 
30 days  60.56 ± 0.09 (60.56)  25.42 ± 0.24 (25.42)  14.01 ± 0.53 (14.01)  0.01 ± 1.71 (0.01)  1.81 ± 0.91 (1.81) 
60 days  63.38 ± 0.09 (63.38  24.36 ± 0.15 (24.36)  12.25 ± 0.74 (12.25)  0.01 ± 1.03 (0.01)  1.98 ± 0.97 (1.98) 
Figure 5. SEM images of the scaffold’s cross-section after (A,B) 15 days (C,D) 30 days and
(E,F) 60 implantation days (H denotes a pore filled with new bone, P refers to implant particles
that result from the degradation process, and NB represents new bone tissue).
According to the EDS analysis and the high-magnification SEM examination of the interfaces
developed between all the scaffolds and the surrounded tissue, the reaction zone was characterized
by the intermediate presence of the calcium phosphate phase with traces of silica. The EDS analysis
was carried out at a series of various points (Figure 5B–D) and by taking distinct points of interest
from the middle to the periphery of the samples to note any changes in the Si/Ca/P ratios. Table 2
offers the descriptive statistics for our database. We saw that the resorption of active biomaterials
was underway. The EDS analysis done with the resi ual scaffold particles i the retrieved tissue
gave a Ca/P tio f v rying relative proportions. The elemental nalys s of the residual scaffold
at different points revealed that some c tegories of particles had distinct mean Ca/P rati s, in
accordance with their degradation status. For the statistical data, a relatively high Ca/P ratio was
obtained in the residual scaffolds—1.366 ≤ Ca/P ≤ 1.74—and at the bone interface—2.02 ≤ Ca/P
≤ 2.34—according to the elemental analysis and when compared to new bone—1.81 ≤ Ca/P ≤ 1.98.
The pre-implantation specific Si ion concentration in the scaffold went from 1.13 ≤ Si ≤ 1.14 in the
material to a post-implantation ion concentration of 0.07 ≤ Si ≤ 1.11, with 0.02 ≤ Si ≤ 0.05 at the bone
interface versus that of new bone of 0.01 ≤ Si ≤ 0.02. What this finding indicates is that the gradual
diffusion of the Ca and Si ions from the biomaterial to the newly forming bone at the interface actually
formed part of the biomaterial’s resorption process.
Table 2. The EDS elemental analysis of the reaction zone at 15, 30 and 60 implantation days. Mean ±
SD (median).
(wt %) O Ca P Si Ca/P Ratio
Implant/Scaffold
15 days 44.73 ± 0.12 (44.73) 35.01 ± 0.25 (32.01) 20.25 ± 0.46 (20.25) 0.11 ± 1.62 (0.11) 1.74 ± 0.86 (1.74)
30 days 45.43 ± 0.13 (45.43) 32.12 ± 0.24 (32.14) 22.36 ± 0.43 (22.36) 0.09 ± 1.83 (0.09) 1.44 ± 0.84 (1.44)
60 days 48.47 ± 0.12 (48.47) 29.62 ± 0.26 (29.62) 21.84 ± 0.35 (21.84) 0.07 ± 1.82 (0.07) 1.36 ± 0.76 (1.36)
Bone Interfase
15 days 50.68 ± 0.11 (50.68) 32.95 ± 0.31 (32.95) 16.32 ± 0.53 (16.32) 0.05 ± 1.63 (0.05) 2.02 ± 0.95 (2.02)
30 days 55.88 ± 0.10 (55.88) 30.23 ± 0.29 (30.23) 13.85 ± 0.54 (13.85) 0.04 ± 1.33 (0.04) 2.18 ± 0.84 (2.18)
60 days 59.15 ± 0.12 (59.15) 28.62 ± 0.32 (28.62) 12.21 ± 0.75 (12.21) 0.02 ± 1.25 (0.02) 2.34 ± 0.96 (2.34)
New bone
15 days 59.69 ± 0.15 (59.69) 26.78 ± 0.16 (26.78) 13.5 ± 0.62 (13.50) 0.02 ± 1.63 (0.02) 1.98 ± 0.83 (1.98)
30 days 60.56 ± 0.09 (60.56) 25.42 ± 0.24 (25.42) 14.01 ± 0.53 (14.01) 0.01 ± 1.71 (0.01) 1.81 ± 0.91 (1.81)
60 days 63.38 ± 0.09 (63.38) 24.36 ± 0.15 (24.36) 12.25 ± 0.74 (12.25) 0.01 ± 1.03 (0.01) 1.98 ± 0.97 (1.98)
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4. Discussion
A polymer replicated method was followed to prepare the Si-TCP scaffolds [22,31–33].
This method proved most useful as it allowed the simple preparation of highly inter-connective
pore structure scaffolds [35,36] within the 1000–300 µm range, which also contained micropores from 1
to 15 µm as well as a high porosity of 80% (Figure 1). The Si-TCP scaffolds’ porous properties covered
the nutrient transportation and cell/bone tissue ingrowth requirements. Small pores favoured hypoxic
conditions and induced osteochondral formation before osteogenesis, while large pores that were
well-vascularized lead to direct osteogenesis [22,23,25,29,30].
The material’s mechanical behavior also sufficed to handle and place the material inside the
surgical site, with a strength of 0.72 MPa. Si-αTCP presented improved mechanical strength
compared to the traditional HA (0.03–0.29 MPa) [36], β-TCP (less than 0.1 MPa) [20], 45S5-Bioglass
(0.42–0.6 MPa) [37] and CaSiO3 (0.33 MPa) [38] scaffolds prepared by the same method. The mechanical
strength obtained for the Si-αTCP scaffolds fell within the same range as that for human sponge bone
(0.2–4.0 MPa) [39]. This indicates that the Si-αTCP scaffolds covered the mechanical requirements for
handling in vivo and in cell culture implantations for bone tissue engineering applications. As the
sintering temperature of Si-αTC scaffolds can go up to 1400 ◦C, which is a substantially higher
temperature than that of HA scaffolds (1100 ◦C), βTCP scaffolds (1200 ◦C) and 45S5 Bioglass (<900 ◦C),
the Si-αTC’s higher sintering temperature can result in dense pore walls and may contribute to
improved mechanical strength.
Ionic substitution plays a key role in the biological chemistry of bone apatite, whose
crystallographic structure is similar to that of hydroxyapatite (Ca5(PO4)3OH). Several anionic (CO3=)
and cationic (K, Na, Sr, Mg) substitutions were induced in crystals of bone apatite [40–47]. These ionic
substitutions resulted in microscopic crystals, which were not only appropriately insoluble for stability
but also adequately reactive to allow the remodeling process of resorption and re-precipitation in vivo.
The incorporation of Si ions herein successfully induced the synthesis of the high-temperature form of
the TCP ceramic, as the XRD analysis indicated.
We herein tested the bone regeneration capacity of the Si-TCP scaffolds by creating critical bone
defects in the tibial bone of rabbits by using empty bone defects as controls.
The Si-αTCP scaffolds’ morphological and structural properties resulted in enhanced new-bone
formation and a greater degradation than the Si-αTCP dense ceramics [19–21]. The novel Si-TCP
scaffolds were superior to the pure TCP dense ceramics in terms of their biological performance in vivo.
Si-αTCP promoted significantly better bone formation and a higher degradation rate.
This degradation is compatible with the bone deposition rate because the presence of fibrous
tissue was limited. More mature bone in the defects treated with Si-αTCP scaffolds was also observed.
The ionic radius of the silicon ions was 0.41 Å, which was a higher radius than that of phosphorus
(0.34 Å). Therefore, the Si-O bond length (0.161) was longer than that of the P-O bond (0.155) and the
ionic radius of the phosphate group (PO43−) was shorter than that of the silicon group (SiO44−) [48–51].
This may diminish the stability of calcium phosphates, thus enhancing their solubility, and may explain
the greater degradability observed for the Si-αTCP scaffolds.
The histomorphometric results of the present study obtained a value of 60.11% for the
Si-αTCP-treated bone defect, which was filled by newly formed bone by 60 healing days. New bone
ingrowth was located in the vicinity of the implant ceramic particles and within the scaffold. This is
possibly owing to the scaffold´s open porosity (76%) and crystallinity. High porosity was seen to
facilitate the resorption process as the pores´ external and external surface areas were exposed to the
medium, which brought about an increase in the calcium and phosphorous ion release—59.0 ± 0.42
(31.57) and 40.52± 0.87 (14.10), respectively—into the intercellular medium for several microns beyond
the scaffold body.
The new bone ingrowths in the implant were more evident at 30 and 60 days and, as the process
further entered the implant, they advanced into the spaces between the implant’s exposed scaffold
particles to form a characteristic interlocking pattern at the interface. The SEM (Figure 5) showed
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massive bone colonization of the implant through the original scaffold pores caused by the structure’s
gradual dissolution. These advanced processes implied that the scaffold material’s free particles
were detected in many areas across the restructuring implant. The fact that the densities inside
the material and at the bone-ceramic interface significantly and gradually reduced implied that the
restorative process not only went from the periphery to the center, but were initiated in an early
material implantation stage by a cellular mechanism [29,30].
5. Conclusions
We successfully prepared bioactive porous Si-αTCP scaffolds with a highly porous large-pore
microstructure by way of a polymer replication method.
The porous Si-αTCP scaffolds possessed a high porosity and a large pore size, as well as an
improved mechanical strength compared to other β-TCP scaffolds obtained by the same method.
Within the limitations of this in vivo rabbit study, it may be stated that the porous Si-αTCP scaffolds
are a valid effective alternative to other materials used for bone tissue engineering. The scaffolds
underwent dissolution while the ion exchange mechanism took place and they were exposed to the
natural environment and were able to transform into a bone-like structure. Thus, they can be fully
integrated into natural bone, which functions while they temporarily take over during the implantation
process. The porous Si-αTCP scaffolds are a promising implant material candidate in orthopedic, oral
and maxillofacial applications given their biological and mechanical properties.
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